Dont hesitate to seek care if unsure
Implications for employers: Although almost half of employers stated that they were interested in the potential for compounded GLP-1 medications, according to WTWs 2025 Best Practices in Healthcare Survey, only 7% said they were very interested, and there has been very little employer uptake of compounded medications
As DiMarchi points out, 'What you're trying to do is take two individual keys and make a master key that is every bit as effective as the two individual parts.' To their surprise they noticed that mice lost more weight when injected with a balanced dual agonist than when given one more centred on GLP-1
OptumRx, 2026 formulary update and prior authorization criteria In February 2026, OptumRx removed the BMI requirement from its cardiovascular reauthorization criteria for Wegovy, simplifying continued authorization for UHC members using the CV indication
Oral semaglutide tablets achieve roughly 0.4% to 1% bioavailability
STEP 1 Fill out a short form and connect with a licensed medical professional 100% online